For patients in the acute phase of chronic airway diseases, on the basis of guideline-directed treatment, the experimental group was given acupuncture treatment, while the control group was given sham acupuncture treatment. The treatment lasted for one week, followed by a 13-week follow-up. For asthma and COPD, PEF and CAT were respectively used as the primary outcome measures to evaluate the clinical efficacy and safety of acupuncture. Based on the improvement of the primary outcome measures, the advantageous population was identified. The mechanism by which acupuncture reduces airway mucus hypersecretion was preliminarily explained.
Meets the diagnostic criteria for acute attack of asthma/AECOPD;
Age range from18 years to 80 years(asthma) and 40 yesrs to 80 years(COPD);
The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.
Patients with combined pulmonary abscess, pulmonary interstitial fibrosis, active pulmonary tuberculosis, bronchiectasis and other pulmonary diseases;
Patients with severe cardiovascular and cerebrovascular diseases (such as malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, grade 3 or above cardiac function, stroke, cerebral hemorrhage, etc.);
Patients with severe liver diseases (such as liver cirrhosis, portal hypertension and bleeding caused by esophageal and gastric fundus varices) and severe kidney diseases (such as dialysis, kidney transplantation, etc.);
Patients with impaired consciousness or various mental disorders who are unable to communicate normally;
Henan University of Traditional Chinese Medicine
Lead sponsor
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Collaborator
Hebei Provincial Hospital of Traditional Chinese Medicine
Collaborator